Literature DB >> 12496288

Identification of bioactive molecules by adipogenesis profiling of organic compounds.

Yongmun Choi1, Yoshinori Kawazoe, Koji Murakami, Hiroyuki Misawa, Motonari Uesugi.   

Abstract

An important step in the postgenomic drug discovery is the construction of high quality chemical libraries that generate bioactive molecules at high rates. Here we report a cell-based approach to composing a focused library of biologically active compounds. A collection of bioactive non-cytotoxic chemicals was identified from a divergent library through the effects on the insulin-induced adipogenesis of 3T3-L1 cells, one of the most drastic and sensitive morphological alterations in cultured mammalian cells. The resulting focused library amply contained unique compounds with a broad range of pharmacological effects, including glucose-uptake enhancement, cytokine inhibition, osteogenesis stimulation, and selective suppression of cancer cells. Adipogenesis profiling of organic compounds generates a focused chemical library for multiple biological effects that are seemingly unrelated to adipogenesis, just as genetic screens with the morphology of fly eyes identify oncogenes and neurodegenerative genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496288     DOI: 10.1074/jbc.M210283200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins.

Authors:  Shinji Kamisuki; Takashi Shirakawa; Akira Kugimiya; Lutfi Abu-Elheiga; Hea-Young Park Choo; Kohei Yamada; Hiroki Shimogawa; Salih J Wakil; Motonari Uesugi
Journal:  J Med Chem       Date:  2011-06-08       Impact factor: 7.446

2.  Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation.

Authors:  Ning Ma; Fuyuan Li; Dan Li; Yang Hui; Xidi Wang; Yu Qiao; Yanfen Zhang; Ying Xiang; Jianying Zhou; Lingyun Zhou; Xiaofei Zheng; Xu Gao
Journal:  Mol Cell Biochem       Date:  2011-11-04       Impact factor: 3.396

3.  Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner.

Authors:  Wei Shao; Carolyn E Machamer; Peter J Espenshade
Journal:  J Lipid Res       Date:  2016-06-20       Impact factor: 5.922

Review 4.  SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy.

Authors:  Xiang Cheng; Jianying Li; Deliang Guo
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

5.  Visualization and quantification of de novo lipogenesis using a FASN-2A-GLuc mouse model.

Authors:  Wenjiao Li; Song Zhang; Xin Fu; Jiehao Zhang; Renlong Li; Haohao Zhang; Qingling An; Weizhen Wang; Zuhong Tian; Changhong Shi; Yongzhan Nie
Journal:  Ann Transl Med       Date:  2022-09

6.  Dipyridamole Inhibits Lipogenic Gene Expression by Retaining SCAP-SREBP in the Endoplasmic Reticulum.

Authors:  Ryan M Esquejo; Manuel Roqueta-Rivera; Wei Shao; Peter E Phelan; Uthpala Seneviratne; Christopher W Am Ende; Paul M Hershberger; Carolyn E Machamer; Peter J Espenshade; Timothy F Osborne
Journal:  Cell Chem Biol       Date:  2020-10-22       Impact factor: 8.116

7.  Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.

Authors:  Xiangyan Li; Yi-Ting Chen; Peizhen Hu; Wen-Chin Huang
Journal:  Mol Cancer Ther       Date:  2014-02-03       Impact factor: 6.261

8.  Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division.

Authors:  Ankur A Gholkar; Keith Cheung; Kevin J Williams; Yu-Chen Lo; Shadia A Hamideh; Chelsea Nnebe; Cindy Khuu; Steven J Bensinger; Jorge Z Torres
Journal:  J Biol Chem       Date:  2016-07-04       Impact factor: 5.157

9.  Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.

Authors:  Xiaohong Ma; Tianyi Zhao; Hong Yan; Kui Guo; Zhiming Liu; Lina Wei; Wei Lu; Chunping Qiu; Jie Jiang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

10.  De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.

Authors:  Saber Tadros; Surendra K Shukla; Ryan J King; Venugopal Gunda; Enza Vernucci; Jaime Abrego; Nina V Chaika; Fang Yu; Audrey J Lazenby; Lyudmyla Berim; Jean Grem; Aaron R Sasson; Pankaj K Singh
Journal:  Cancer Res       Date:  2017-08-15       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.